| CTRI Number |
CTRI/2025/10/096316 [Registered on: 22/10/2025] Trial Registered Prospectively |
| Last Modified On: |
18/10/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Faster recovery after surgery in face injury |
|
Scientific Title of Study
|
ERAS pathway in maxillofacial trauma: A prospective randomised comparison with conventional study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vidyashree G S |
| Designation |
Junior Resident |
| Affiliation |
Post Graduate Institute Of Medical Education and Research |
| Address |
Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh,
Chandigarh CHANDIGARH 160012 India |
| Phone |
9113606482 |
| Fax |
|
| Email |
vidyashreegs12@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Nidhi Bhatia |
| Designation |
Professor |
| Affiliation |
Post Graduate Institute Of Medical Education and Research |
| Address |
Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh
Chandigarh CHANDIGARH 160012 India |
| Phone |
9914207483 |
| Fax |
|
| Email |
nidhi.bhatia75@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Nidhi Bhatia |
| Designation |
Professor |
| Affiliation |
Post Graduate Institute Of Medical Education and Research |
| Address |
Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh
Chandigarh CHANDIGARH 160012 India |
| Phone |
9914207483 |
| Fax |
|
| Email |
nidhi.bhatia75@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Department of Anaesthesia and Intensive care |
| Address |
PostGraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Nidhi Bhatia |
PostGraduate Institute of Medical Education and Research |
Department of Anesthesia and Intensive Care, Level IV, Nehru Hospital, Sector 12,Chandigarh,160012 Chandigarh CHANDIGARH |
9914207483
nidhi.bhatia75@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee (Intramural) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Conventional care |
Patient management will be done according to existing standard of care |
| Intervention |
ERAS |
patient management will be done according to Enhanced Recovery After Surgery (ERAS) protocol |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
diagnosed with maxillofacial injuries requiring surgical fixation under general anaesthesia |
|
| ExclusionCriteria |
| Details |
Head injuries
Polytrauma
Scheduled for multiple surgeries
A diagnosed Psychiatric illness
Already intubated or tracheostomised
Refusal to provide consent |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Length of hospital stay |
at the time of discharge |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Quality of Recovery using QoR-15 scale |
24 hours postoperatively, 48 hours postoperatively, at discharge
|
| Patient satisfaction at discharge using 5 level likert scale |
at discharge |
| Perioperative opioid use |
From day of admission to day of discharge |
| Compications, if any, including airway obstruction, aspiration, difficult intubation/extubation, intraoperative bleeding, local anaesthesia toxicity, postoperative infection, surgical hardware failure or instability. |
from day of admission to day of discahrge |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
ERAS pathways are patient centred, evidence based protocols involving multidisciplinary team replacing traditional practices of patient management and thereby enhance patient recovery and reduce number of days spent in the hospital. There are ERAS protocols for surgeries across various specialties but none for maxillofacial trauma. hence, this study is designed with the aim of formulating ERAS protocol for patients with maxillofacial injuries. The methodology involves randomising patients with maxillofacial trauma meeting inclusion and exclusion criteria into two groups. One group receives the conventional care while the other group receives treatment according to the ERAS pathway formulated by us based on ERAS consensus guidelines for colorectal surgery. Length of hospital stay are compared along with other outcomes such as quality of recovery, perioperative opioid use, patient satisfaction and any complications between both the groups.
|